Network meta-analysis of Chinese patent medicine adjuvant treatment of poststroke depression
Conclusion:
This study will provide systematic evidence-based medicine evidence for Chinese patent medicine adjuvant treatment for poststroke depression, and help clinicians, patients with poststroke depression and decision-makers to make more effective, safer, and economic optimal treatment plan in the decision-making process.
PROSPERO registration number:
CRD42020164543
Source: Medicine - Category: Internal Medicine Tags: Research Article: Study Protocol Systematic Review Source Type: research
More News: Brain | China Health | Complementary Medicine | Computers | Databases & Libraries | Depression | Herbs | Internal Medicine | Neurology | Neuroscience | Science | Stroke | Study